Does IMATINIB Cause Thrombotic microangiopathy? 48 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 48 reports of Thrombotic microangiopathy have been filed in association with IMATINIB (Imatinib). This represents 0.1% of all adverse event reports for IMATINIB.
48
Reports of Thrombotic microangiopathy with IMATINIB
0.1%
of all IMATINIB reports
20
Deaths
32
Hospitalizations
How Dangerous Is Thrombotic microangiopathy From IMATINIB?
Of the 48 reports, 20 (41.7%) resulted in death, 32 (66.7%) required hospitalization, and 3 (6.3%) were considered life-threatening.
Is Thrombotic microangiopathy Listed in the Official Label?
Yes, Thrombotic microangiopathy is listed as a known adverse reaction in the official FDA drug label for IMATINIB.
What Other Side Effects Does IMATINIB Cause?
Death (9,708)
Drug ineffective (2,628)
Nausea (2,379)
Diarrhoea (2,203)
Fatigue (1,810)
Malignant neoplasm progression (1,716)
Vomiting (1,599)
Malaise (1,361)
Drug intolerance (1,354)
Drug resistance (1,293)
What Other Drugs Cause Thrombotic microangiopathy?
TACROLIMUS (1,982)
MYCOPHENOLATE MOFETIL (820)
CYCLOSPORINE (724)
GEMCITABINE (648)
ECULIZUMAB (636)
CYCLOPHOSPHAMIDE (602)
FLUDARABINE (480)
METHOTREXATE (447)
CARFILZOMIB (350)
METHYLPREDNISOLONE (345)
Which IMATINIB Alternatives Have Lower Thrombotic microangiopathy Risk?
IMATINIB vs IMBRUVICA
IMATINIB vs IMDEVIMAB
IMATINIB vs IMEGLIMIN
IMATINIB vs IMETELSTAT
IMATINIB vs IMIDAPRIL